Showing results (1-10 of 244) with videos related to

Sort By:
Pageof 25
Dermatologic Clinics|January 8, 2000
New and emerging therapies in the treatment of blistering diseasesN J Korman
The Journal of Investigative Dermatology|December 1, 1995
In situ-bound antibodies eluted from the skin of patients with bullous pemphigoid are preferentially directed against the 230-kD bullous pemphigoid antigenN J Korman
Dermatologic Clinics|October 1, 1990
PemphigusN J Korman
The British Journal of Dermatology|June 22, 2019
Management of psoriasis as a systemic disease: what is the evidence?N J Korman
Dermatologic Clinics|November 14, 2001
New immunomodulating drugs in autoimmune blistering diseasesN J Korman
Dermatologic Clinics|July 1, 1993
Bullous pemphigoidN J Korman
Cancer Immunology Research|April 5, 2017
Masterful Antibodies: Checkpoint BlockadeNils Lonberg, Alan J Korman
Expert Opinion on Pharmacotherapy|November 18, 2006
Bullous pemphigoid treatment reviewTimothy Patton, Neil J Korman
Trends in Molecular Medicine|November 1, 2024
Fc-optimized checkpoint antibodies for cancer immunotherapyRony Dahan, Alan J Korman
The British Journal of Dermatology|December 1, 1995
Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoidN J Korman, S G Woods
Pageof 25